Subscribe to our Science Newsletter to explore the wide worlds of science, health and technology.
Thank you. Please check your inbox to confirm.
Aducanumab, a new drug that some researchers are calling the most promising yet in the fight against Alzheimer’s, suggests it is possible to clear the brain of the amyloid protein, a characteristic of the disease.
Support Provided By:
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
By Don Babwin, Julie Watson, Associated Press
By Associated Press
By Zeke Miller, Associated Press
By David Rising, Geir Moulson, Associated Press
By Ben Finley, Associated Press
By Sarah El Deeb, Associated Press
By Kate Wong, Scientific American
By Matthew Lee, Associated Press
By Andrew Taylor, Associated Press
By Brian Melley, Associated Press
By Rodney Muhumuza, Hilary Uguru, Cara Anna, Associated Press
By Joseph Pisani, Associated Press
By Frances D'Emilio, Nicole Winfield, Associated Press
By Courtney Vinopal
By Jessica Yarvin
By Molly Finnegan
By Lisa Mascaro, Associated Press